A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (vol 10, 1796, 2020) by McWilliam, Stephen J et al.
1Scientific RepoRtS |         (2020) 10:4730  | https://doi.org/10.1038/s41598-020-61783-9
www.nature.com/scientificreports
Author correction: A randomised 
controlled trial of rosuvastatin for 
the prevention of aminoglycoside-
induced kidney toxicity in children 
with cystic fibrosis
Stephen J. McWilliam  , Anna Rosala-Hallas, Ashley p. Jones, Victoria Shaw, 
William Greenhalf, thomas Jaki, Alan R. Smyth, Rosalind L. Smyth & Munir pirmohamed
Correction to: Scientific Reports https://doi.org/10.1038/s41598-020-58790-1, published online 04 February 2020
In this Article, the Competing Interests statement was omitted. The Competing Interests section should read:
“MP has a PhD studentship jointly funded by EPSRC and Astra Zeneca on drug-drug interactions, but this is not 
specifically focusing on rosuvastatin or other statins.”
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